Quest Diagnostics Inc Business Combination, Acquisition Related Costs
Quest Diagnostics Inc (DGX) reported Business Combination, Acquisition Related Costs of $15.10 million for the 3-month period ending 2011-06-30, per its 10-K filed 2013-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2013-02-27
- Quest Diagnostics Inc business combination, acquisition related costs for the quarter ending 2011-06-30 was $15.10M.
- Quest Diagnostics Inc business combination, acquisition related costs for the quarter ending 2011-03-31 was $4.70M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month |
|---|---|---|
| 2011-06-30 | $15.10M 10-K · filed 2013-02-27 | $19.80M derived: sum of 2 quarters · filed 2013-02-27 |
| 2011-03-31 | $4.70M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |